UniProt ID | KAT5_HUMAN | |
---|---|---|
UniProt AC | Q92993 | |
Protein Name | Histone acetyltransferase KAT5 | |
Gene Name | KAT5 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 513 | |
Subcellular Localization | Nucleus . Nucleus, nucleolus. Cytoplasm, perinuclear region. Upon stimulation with EDN1, it is exported from the nucleus to the perinuclear region and UV irradiation induces translocation into punctuate subnuclear structures named nuclear bodies. | |
Protein Description | Catalytic subunit of the NuA4 histone acetyltransferase complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A. This modification may both alter nucleosome-DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. This complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and DNA repair. NuA4 may also play a direct role in DNA repair when recruited to sites of DNA damage. Directly acetylates and activates ATM. Component of a SWR1-like complex that specifically mediates the removal of histone H2A.Z/H2AFZ from the nucleosome. Relieves NR1D2-mediated inhibition of APOC3 expression by acetylating NR1D2. Promotes FOXP3 acetylation and positively regulates its transcriptional repressor activity. [PubMed: 17360565 Acetylates RAN at 'Lys-134'] | |
Protein Sequence | MAEVGEIIEGCRLPVLRRNQDNEDEWPLAEILSVKDISGRKLFYVHYIDFNKRLDEWVTHERLDLKKIQFPKKEAKTPTKNGLPGSRPGSPEREVPASAQASGKTLPIPVQITLRFNLPKEREAIPGGEPDQPLSSSSCLQPNHRSTKRKVEVVSPATPVPSETAPASVFPQNGAARRAVAAQPGRKRKSNCLGTDEDSQDSSDGIPSAPRMTGSLVSDRSHDDIVTRMKNIECIELGRHRLKPWYFSPYPQELTTLPVLYLCEFCLKYGRSLKCLQRHLTKCDLRHPPGNEIYRKGTISFFEIDGRKNKSYSQNLCLLAKCFLDHKTLYYDTDPFLFYVMTEYDCKGFHIVGYFSKEKESTEDYNVACILTLPPYQRRGYGKLLIEFSYELSKVEGKTGTPEKPLSDLGLLSYRSYWSQTILEILMGLKSESGERPQITINEISEITSIKKEDVISTLQYLNLINYYKGQYILTLSEDIVDGHERAMLKRLLRIDSKCLHFTPKDWSKRGKW | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 (in isoform 4) | Phosphorylation | - | 46.07 | 25159151 | |
6 (in isoform 3) | Phosphorylation | - | 46.07 | 25159151 | |
33 | Phosphorylation | WPLAEILSVKDISGR CCHHHEEEEEECCCC | 32.55 | 24719451 | |
35 | Ubiquitination | LAEILSVKDISGRKL HHHEEEEEECCCCEE | 46.07 | 2190698 | |
35 (in isoform 1) | Ubiquitination | - | 46.07 | 21906983 | |
35 (in isoform 3) | Phosphorylation | - | 46.07 | 21815630 | |
35 (in isoform 4) | Phosphorylation | - | 46.07 | 21815630 | |
44 | Phosphorylation | ISGRKLFYVHYIDFN CCCCEEEEEEEEECC | 9.21 | - | |
52 | Acetylation | VHYIDFNKRLDEWVT EEEEECCHHHHHHHH | 55.09 | 19608861 | |
68 (in isoform 3) | Ubiquitination | - | 4.95 | 21906983 | |
68 (in isoform 2) | Ubiquitination | - | 4.95 | 21906983 | |
76 | Acetylation | QFPKKEAKTPTKNGL CCCHHHCCCCCCCCC | 57.01 | 22470428 | |
77 | Phosphorylation | FPKKEAKTPTKNGLP CCHHHCCCCCCCCCC | 43.15 | 26074081 | |
79 | Phosphorylation | KKEAKTPTKNGLPGS HHHCCCCCCCCCCCC | 42.23 | 26074081 | |
80 | Acetylation | KEAKTPTKNGLPGSR HHCCCCCCCCCCCCC | 50.66 | 22470428 | |
85 | Acetylation | PTKNGLPGSRPGSPE CCCCCCCCCCCCCCC | 41.13 | 19608861 | |
86 (in isoform 2) | Phosphorylation | - | 33.10 | 25159151 | |
86 | Phosphorylation | TKNGLPGSRPGSPER CCCCCCCCCCCCCCC | 33.10 | 23401153 | |
90 | Phosphorylation | LPGSRPGSPEREVPA CCCCCCCCCCCCCCC | 26.69 | 23401153 | |
90 (in isoform 2) | Phosphorylation | - | 26.69 | 28731282 | |
98 | Phosphorylation | PEREVPASAQASGKT CCCCCCCCCCCCCCC | 18.16 | 30624053 | |
102 | Phosphorylation | VPASAQASGKTLPIP CCCCCCCCCCCCCEE | 28.83 | 23312004 | |
103 (in isoform 2) | Phosphorylation | - | 29.95 | 25849741 | |
104 | Acetylation | ASAQASGKTLPIPVQ CCCCCCCCCCCEEEE | 44.38 | 26051181 | |
106 (in isoform 2) | Phosphorylation | - | 4.05 | 25159151 | |
119 (in isoform 4) | Phosphorylation | - | 37.25 | 25159151 | |
120 | Acetylation | TLRFNLPKEREAIPG EEEECCCCCCCCCCC | 72.99 | 104995799 | |
123 (in isoform 4) | Phosphorylation | - | 52.63 | 28731282 | |
136 (in isoform 4) | Phosphorylation | - | 33.67 | 25849741 | |
139 (in isoform 4) | Phosphorylation | - | 4.40 | 25159151 | |
148 | Acetylation | QPNHRSTKRKVEVVS CCCCCCCCCCEEEEC | 52.01 | 104995815 | |
150 | Acetylation | NHRSTKRKVEVVSPA CCCCCCCCEEEECCC | 44.28 | 22470428 | |
155 | Phosphorylation | KRKVEVVSPATPVPS CCCEEEECCCCCCCC | 17.62 | 30266825 | |
158 | Phosphorylation | VEVVSPATPVPSETA EEEECCCCCCCCCCC | 28.36 | 30266825 | |
162 | Phosphorylation | SPATPVPSETAPASV CCCCCCCCCCCCCCC | 48.06 | 19690332 | |
164 | Phosphorylation | ATPVPSETAPASVFP CCCCCCCCCCCCCCC | 42.13 | 25850435 | |
168 | Phosphorylation | PSETAPASVFPQNGA CCCCCCCCCCCCCCH | 24.19 | 27251275 | |
187 | Acetylation | VAAQPGRKRKSNCLG HHCCCCCCCCCCCCC | 70.82 | 22470428 | |
189 | Acetylation | AQPGRKRKSNCLGTD CCCCCCCCCCCCCCC | 49.40 | 20100829 | |
190 | Phosphorylation | QPGRKRKSNCLGTDE CCCCCCCCCCCCCCC | 36.49 | 30266825 | |
195 | Phosphorylation | RKSNCLGTDEDSQDS CCCCCCCCCCCCCCC | 24.22 | 30266825 | |
199 | Phosphorylation | CLGTDEDSQDSSDGI CCCCCCCCCCCCCCC | 33.56 | 23401153 | |
202 | Phosphorylation | TDEDSQDSSDGIPSA CCCCCCCCCCCCCCC | 23.77 | 30266825 | |
203 | Phosphorylation | DEDSQDSSDGIPSAP CCCCCCCCCCCCCCC | 48.42 | 30266825 | |
208 | Phosphorylation | DSSDGIPSAPRMTGS CCCCCCCCCCCCCCC | 49.32 | 30266825 | |
227 | Phosphorylation | RSHDDIVTRMKNIEC CCHHHHHHHHHCEEE | 25.94 | - | |
230 | Acetylation | DDIVTRMKNIECIEL HHHHHHHHCEEEEEC | 52.03 | - | |
230 | Ubiquitination | DDIVTRMKNIECIEL HHHHHHHHCEEEEEC | 52.03 | - | |
249 | Acetylation | LKPWYFSPYPQELTT CCCCCCCCCCHHHCH | 34.62 | 16001085 | |
263 | Acetylation | TLPVLYLCEFCLKYG HHHHHHHHHHHHHHC | 2.08 | 16001085 | |
263 (in isoform 3) | Ubiquitination | - | 2.08 | - | |
268 | Acetylation | YLCEFCLKYGRSLKC HHHHHHHHHCCHHHH | 47.00 | 16001085 | |
274 | Ubiquitination | LKYGRSLKCLQRHLT HHHCCHHHHHHHHHH | 33.86 | - | |
281 | Phosphorylation | KCLQRHLTKCDLRHP HHHHHHHHHCCCCCC | 24.41 | - | |
282 | Ubiquitination | CLQRHLTKCDLRHPP HHHHHHHHCCCCCCC | 31.92 | 16001085 | |
282 | Acetylation | CLQRHLTKCDLRHPP HHHHHHHHCCCCCCC | 31.92 | 16001085 | |
294 | Phosphorylation | HPPGNEIYRKGTISF CCCCCCEEECCEEEE | 10.49 | - | |
296 | Ubiquitination | PGNEIYRKGTISFFE CCCCEEECCEEEEEE | 43.35 | - | |
301 | Acetylation | YRKGTISFFEIDGRK EECCEEEEEEECCCC | 5.87 | 16001085 | |
307 (in isoform 3) | Ubiquitination | - | 35.31 | - | |
310 | Ubiquitination | EIDGRKNKSYSQNLC EECCCCCCCHHHHHH | 54.53 | - | |
315 | Acetylation | KNKSYSQNLCLLAKC CCCCHHHHHHHHHHH | 27.12 | 16001085 | |
315 (in isoform 3) | Ubiquitination | - | 27.12 | - | |
327 | Acetylation | AKCFLDHKTLYYDTD HHHHHCCCCEECCCC | 39.63 | 22470428 | |
343 (in isoform 3) | Ubiquitination | - | 22.68 | - | |
383 | Acetylation | YQRRGYGKLLIEFSY CCCCCCHHEEEEEEE | 31.47 | 22470428 | |
404 | Ubiquitination | GKTGTPEKPLSDLGL CCCCCCCCCHHHHCC | 53.08 | - | |
404 | Acetylation | GKTGTPEKPLSDLGL CCCCCCCCCHHHHCC | 53.08 | 26051181 | |
430 | Sumoylation | LEILMGLKSESGERP HHHHHCCCCCCCCCC | 46.58 | - | |
430 | Sumoylation | LEILMGLKSESGERP HHHHHCCCCCCCCCC | 46.58 | 17704809 | |
431 | Phosphorylation | EILMGLKSESGERPQ HHHHCCCCCCCCCCE | 41.88 | - | |
437 (in isoform 3) | Ubiquitination | - | 26.14 | - | |
451 | Ubiquitination | ISEITSIKKEDVIST HHHHCCCCHHHHHHH | 50.29 | - | |
451 | Sumoylation | ISEITSIKKEDVIST HHHHCCCCHHHHHHH | 50.29 | 17704809 | |
451 | Sumoylation | ISEITSIKKEDVIST HHHHCCCCHHHHHHH | 50.29 | - | |
472 | Phosphorylation | INYYKGQYILTLSED HHHHCCCEEEEEEHH | 13.43 | 18083107 | |
498 | Ubiquitination | RLLRIDSKCLHFTPK HHHHHCCCCCCCCCC | 36.75 | - | |
505 | Ubiquitination | KCLHFTPKDWSKRGK CCCCCCCCHHHHCCC | 69.63 | - | |
531 (in isoform 3) | Ubiquitination | - | - | ||
538 (in isoform 3) | Ubiquitination | - | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
44 | Y | Phosphorylation | Kinase | ABL | P00519 | PSP |
86 | S | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
86 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
86 | S | Phosphorylation | Kinase | GSK3 | - | Uniprot |
90 | S | Phosphorylation | Kinase | CDK1 | P06493 | Uniprot |
90 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
106 | T | Phosphorylation | Kinase | MAPK14 | Q16539 | GPS |
158 | T | Phosphorylation | Kinase | MAPK14 | Q16539 | GPS |
294 | Y | Phosphorylation | Kinase | ABL1 | P00519 | GPS |
- | K | Ubiquitination | E3 ubiquitin ligase | MDM2 | Q00987 | PMID:11927554 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of KAT5_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-52, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-86 AND SER-90, AND MASSSPECTROMETRY. | |
"Tip60 acetyltransferase activity is controlled by phosphorylation."; Lemercier C., Legube G., Caron C., Louwagie M., Garin J., Trouche D.,Khochbin S.; J. Biol. Chem. 278:4713-4718(2003). Cited for: PHOSPHORYLATION AT SER-86 AND SER-90, AND MUTAGENESIS OF SER-86;SER-90; LEU-254; LEU-257 AND GLY-380. | |
Sumoylation | |
Reference | PubMed |
"Functional characterization of TIP60 sumoylation in UV-irradiated DNAdamage response."; Cheng Z., Ke Y., Ding X., Wang F., Wang H., Wang W., Ahmed K., Liu Z.,Xu Y., Aikhionbare F., Yan H., Liu J., Xue Y., Yu J., Powell M.,Liang S., Wu Q., Reddy S.E., Hu R., Huang H., Jin C., Yao X.; Oncogene 27:931-941(2008). Cited for: SUMOYLATION AT LYS-430 AND LYS-451, MUTAGENESIS OF LYS-430 ANDLYS-451, SUBCELLULAR LOCATION, IDENTIFICATION BY MASS SPECTROMETRY,AND IDENTIFICATION OF KAT5-UBE2I-SENP6 COMPLEX. |